Trial · NCT03317002
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in Creatinine-normalized u-LTE4 at Week 4 | Baseline and 4 weeks | Number of participants analysed differs from participant flow module due to missing data | Ratio | GEOMETRIC_MEAN |
| SECONDARY | Change From Baseline in Creatinine-normalized u-LTE4 at Week 12 | Baseline and 12 weeks | Number of participants analysed differs from participant flow module due to missing data | Ratio | GEOMETRIC_MEAN |
| SECONDARY | Change From Baseline in CFVR at Week 12 | Baseline and 12 weeks | Number of participants analysed differs from participant flow module due to missing data | Ratio | GEOMETRIC_MEAN |
| SECONDARY | Change From Baseline in CFVR at Week 4 | Baseline and 4 weeks | Number of participants analysed differs from participant flow module due to missing data | Ratio | GEOMETRIC_MEAN |
| SECONDARY | Summary of Plasma Concentrations of AZD5718 | 16 weeks | Number of participants analysed differs from participant flow module due to missing data | nmol/L | GEOMETRIC_MEAN |
| SECONDARY | Change From Baseline in LAD Hypereamic Flow at 4 Weeks | Baseline and 4 weeks | Number of participants analysed differs from participant flow module due to missing data | m/sec | MEAN |
| SECONDARY | Change From Baseline in LVEF at 4 Weeks | Baseline and 4 weeks | Number of participants analysed differs from participant flow module due to missing data | percent LVEF | MEAN |
| SECONDARY | Change From Baseline in LV Longitudinal Early Diastolic Strain Rate at 4 Weeks | Baseline and 4 weeks | Number of participants analysed differs from participant flow module due to missing data | 1/s | GEOMETRIC_MEAN |
| SECONDARY | Change From Baseline in LV-GLS at Rest at Week 4 | Baseline and 4 weeks | Number of participants analysed differs from participant flow module due to missing data | Percent LV-GLS | MEAN |
| SECONDARY | Change From Baseline in LV-GCS at Rest at Week 4 | Baseline and 4 weeks | Number of participants analysed differs from participant flow module due to missing data | Percent | MEAN |
| SECONDARY | Change From Baseline in LAD Resting Mean Diastolic Flow Velocity at 4 Weeks | Baseline and 4 weeks | Number of participants analysed differs from participant flow module due to missing data | m/sec | GEOMETRIC_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03317002/outcomes